Patent details

Basic Information

Publication number:

EP2293795

PCT Application Number:

PCT/EP/2009/056891

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097575997

PCT Publication Number:

WO/2009/147218

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Pharmaceutical combination

French Title of Invention:

Association pharmacologique

German Title of Invention:

Pharmazeutische Kombination

SPC Number:

Dates

Filing date:

04/06/2009

Grant date:

12/08/2015

EP Publication Date:

12/08/2015

PCT Publication Date:

10/12/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/03/2011

EP B1 Publication Date:

12/08/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/06/2021

Expiration date:

04/06/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/06/2009

 

 

Name:

Boehringer Ingelheim International GmbH

Address:

Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

1

Name:

HILBERG Frank

Address:

Germany (DE)

2

Name:

STEFANIC Martin Friedrich

Address:

Germany (DE)

3

Name:

SHAPIRO David

Address:

United States (US)

4

Name:

KAISER Rolf

Address:

Germany (DE)

Priority

1

Priority Number:

08157749

Priority Date:

06/06/2008

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

78882 P

Priority Date:

08/07/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/48;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

18/06/2020

Last Annual Fee Paid Number:

12

Last Annual Fee Paid Amount:

165 Euro

Payer:

DENNEMEYER & CO

Filing date	Document type	Number of pages